FADS1 rs174549 Polymorphism May Predict a Favorable Response to Chemoradiotherapy in Oral Cancer Patients.

doi:10.1016/j.joms.2016.07.005

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

FADS1 rs174549 Polymorphism May Predict a Favorable Response to Chemoradiotherapy in Oral Cancer Patients.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons - 1 Jan 2017

Chen Fa, He Baochang, Yan Lingjun, Qiu Yu, Lin Lisong, Cai Lin

Abstract excerpt

PURPOSE: The fatty acid desaturase 1 (FADS1) gene variant is a novel susceptibility marker for laryngeal squamous cell carcinoma identified by a recent genome-wide association study, but it is still unclear whether this genetic variant continues to influence oral cancer recurrence or death. The purpose of this study was to evaluate the role of FADS1 rs174549 polymorphism and its interaction with postoperative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Delta-5 Fatty Acid Desaturase

Share to Disease-Free Survival

Share to Fatty Acid Desaturases

Share to Kaplan-Meier Estimate

Share to Mouth Neoplasms

Share to Prognosis

Share to Proportional Hazards Models

Source

Open in PubMed

Identifiers

PMID: 27542551
DOI: 10.1016/j.joms.2016.07.005

Genes

FADS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FADS1 rs174549 Polymorphism May Predict a Favorable Response to Chemoradiotherapy in Oral Cancer Patients.PMID 27542551Read ↗

[Fatty acid desaturase 1 polymorphism, marine fish oil intake and the risk of oral squamous cell carcinoma: A case-control study].Semantic proximity Read ↗

Differential cancer risk and survival in Indian oral cancer patients with genic region FAS and FASL polymorphisms.Semantic proximity Read ↗

Prognostic value of transforming growth factor beta receptor 1 polymorphisms in patients with oral cancer.Semantic proximity Read ↗

The Contribution of Flap Endonuclease 1 Genotypes to Oral Cancer Risk.Semantic proximity Read ↗

NBS1 rs2735383 polymorphism is associated with an increased risk of laryngeal carcinoma.Semantic proximity Read ↗

Association of XRCC2 rs2040639 with the survival of patients with oral squamous cell carcinoma undergoing concurrent chemoradiotherapy.Semantic proximity Read ↗

Selected E2F2 Polymorphisms in Oral and Oropharyngeal Squamous Cell Carcinoma.Semantic proximity Read ↗

Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.Semantic proximity Read ↗

Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma.Semantic proximity Read ↗

FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers.Semantic proximity Read ↗

Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.Semantic proximity Read ↗

Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.